نتائج البحث

المساهمون: de Braud, F., Machiels, J. -P. H., Boggiani, D., Rottey, S. W. H., Duca, M., Laruelle, M., Salvagni, S., Damian, S., Lapeire, L. D. F., Tiseo, M., Dermine, A., Ould-Kaci, M., Braunger, J., Rascher, J., Fischer, D., Hoefler, J., Mariani, G. L., Cresta, S.

مصطلحات موضوعية: BI 860585, Clinical trial, Maximum tolerated dose, MTOR serine-threonine kinase, Pharmacokinetic, Phase 1

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000549246800001; volume:12; issue:6; firstpage:1425; journal:CANCERS; http://hdl.handle.net/11381/2881519Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085743591

الإتاحة: https://doi.org/10.3390/cancers12061425Test
http://hdl.handle.net/11381/2881519Test

View record in BASE

5

دورية أكاديمية

Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile

المؤلفون: Lorusso D., Maltese G., Sabatucci I., Cresta S., Matteo C., Ceruti T., D'Incalci M., Zucchetti M., Raspagliesi F., Sonetto C., Sinno V., Ronzulli D., Giolitto S., de Braud F.

المساهمون: D. Lorusso, G. Maltese, I. Sabatucci, S. Cresta, C. Matteo, T. Ceruti, M. D'Incalci, M. Zucchetti, F. Raspagliesi, C. Sonetto, V. Sinno, D. Ronzulli, S. Giolitto, F. de Braud

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocol, Bevacizumab, Female, Human, Indole, Maximum Tolerated Dose, Middle Aged, Ovarian Neoplasms, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33369704; info:eu-repo/semantics/altIdentifier/wos/WOS:000603274300002; volume:16; issue:1; firstpage:59; lastpage:68; numberofpages:10; journal:TARGETED ONCOLOGY; http://hdl.handle.net/2434/908570Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098229022

الإتاحة: https://doi.org/10.1007/s11523-020-00780-4Test
http://hdl.handle.net/2434/908570Test

View record in BASE

6

دورية أكاديمية

991P Treatment-related adverse events (TRAEs) occurring during dostarlimab therapy in the GARNET study

المؤلفون: André, T., Berton, D., Oaknin, A., Moreno Garcia, V., Curigliano, G., Trigo, J., Barretina-Ginesta, M-P., Ellard, S., Tinker, A.V., Miller, R., Pikiel, J., Boni, V., Cresta, S., Pothuri, B., Roda Perez, D., Drew, Y., Veneris, J., Im, E., Banerjee, S.

المصدر: Annals of Oncology ; volume 32, page S845-S846 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.1375Test
https://api.elsevier.com/content/article/PII:S0923753421036048?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753421036048?httpAccept=text/plainTest

View record in BASE

7

دورية أكاديمية

1779P Revolutionizing clinical trial units in the pandemic era

المؤلفون: Cagnazzo, C., Franchina, V., Maggiora, P., Stabile, S., Taverniti, C., Guarrera, A., Federici, I., Testoni, S., Monti, M., Cresta, S., Fragioli, F.

المصدر: Annals of Oncology ; volume 31, page S1030 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.1843Test
https://api.elsevier.com/content/article/PII:S0923753420418393?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420418393?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET)

المؤلفون: Jhaveri, K., Juric, D., Yap, Y-S., Cresta, S., Layman, R., Duhoux, F., Terret, C., De Vita, S., Kundamal, N., He, W., Balbin, A., Sheng, Q., Crystal, A., Curigliano, G.

المصدر: Annals of Oncology ; volume 31, page S62 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2020.03.311Test
https://api.elsevier.com/content/article/PII:S0923753420393054?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753420393054?httpAccept=text/plainTest

View record in BASE

9

دورية أكاديمية

MA06.03 KontRASt-01: Preliminary Safety and Efficacy of JDQ443 + TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors

المؤلفون: Negrao, M.V., Cassier, P.A., Solomon, B., Schuler, M., Rohrberg, K., Cresta, S., Dooms, C., Tan, D.S.W., Loong, H.H-f., Amatu, A., Assmann, K. Krueger, Fairchild, L., Sansregret, L., Fan, L., Farago, A.F., Cho, B.C.

المصدر: Journal of Thoracic Oncology ; volume 18, issue 11, page S117-S118 ; ISSN 1556-0864

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

الإتاحة: https://doi.org/10.1016/j.jtho.2023.09.151Test
https://api.elsevier.com/content/article/PII:S155608642300953X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S155608642300953X?httpAccept=text/plainTest

View record in BASE

10

دورية أكاديمية

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

المؤلفون: Mariani G, Galli G, Cavalieri S, Valagussa P, Bianchi GV, Capri G, Cresta S, Ferrari L, Damian S, Duca M, de Braud F, Moliterni A

المساهمون: G. Mariani, G. Galli, S. Cavalieri, P. Valagussa, G. Bianchi, G. Capri, S. Cresta, L. Ferrari, S. Damian, M. Duca, F. de Braud, A. Moliterni

مصطلحات موضوعية: adjuvant chemotherapy, breast cancer, neo-adjuvant chemotherapy, safety, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30810258; info:eu-repo/semantics/altIdentifier/wos/WOS:000460317400009; volume:25; issue:2; firstpage:237; lastpage:242; numberofpages:6; journal:THE BREAST JOURNAL; http://hdl.handle.net/2434/647579Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85062375518

الإتاحة: https://doi.org/10.1111/tbj.13197Test
http://hdl.handle.net/2434/647579Test

View record in BASE

تنقيح النتائج